Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NU7441 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
NU7441 inhibits DNA-PK, which may result in increased sensitivity of tumor cells to radiation and chemotherapy (PMID: 16707462, PMID: 31785810). |
| DrugClasses | DNA_PK Inhibitor 9 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Doxorubicin + NU7441 | Doxorubicin NU7441 | 0 | 0 |
| Etoposide + NU7441 | Etoposide NU7441 | 0 | 0 |
| NU7441 | NU7441 | 0 | 0 |
| NU7441 + Radiotherapy | NU7441 Radiotherapy | 0 | 0 |